Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.
Feelders RA, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R, de Jong FH, van der Lely AJ, de Herder WW, Hofland LJ, Lamberts SW. Feelders RA, et al. Among authors: lamberts sw. N Engl J Med. 2010 May 13;362(19):1846-8. doi: 10.1056/NEJMc1000094. N Engl J Med. 2010. PMID: 20463350 Clinical Trial. No abstract available.
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
van der Pas R, de Bruin C, Leebeek FW, de Maat MP, Rijken DC, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, de Jong FH, van der Lely AJ, de Herder WW, Lamberts SW, Hofland LJ, Feelders RA. van der Pas R, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2012 Apr;97(4):1303-10. doi: 10.1210/jc.2011-2753. Epub 2012 Jan 25. J Clin Endocrinol Metab. 2012. PMID: 22278425 Clinical Trial.
Octreotide.
Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Lamberts SW, et al. N Engl J Med. 1996 Jan 25;334(4):246-54. doi: 10.1056/NEJM199601253340408. N Engl J Med. 1996. PMID: 8532003 Review. No abstract available.
[Cushing's syndrome. II. New forms of treatment].
van Aken MO, Feelders RA, van der Lely AJ, Romijn JA, Lamberts SW, de Herder WW. van Aken MO, et al. Among authors: lamberts sw. Ned Tijdschr Geneeskd. 2006 Oct 28;150(43):2365-9. Ned Tijdschr Geneeskd. 2006. PMID: 17100127 Review. Dutch.
Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy.
van der Pas R, van Esch JH, de Bruin C, Danser AH, Pereira AM, Zelissen PM, Netea-Maier R, Sprij-Mooij DM, van den Berg-Garrelds IM, van Schaik RH, Lamberts SW, van den Meiracker AH, Hofland LJ, Feelders RA. van der Pas R, et al. Among authors: lamberts sw. Eur J Endocrinol. 2014 Feb 1;170(2):181-91. doi: 10.1530/EJE-13-0477. Print 2014 Feb. Eur J Endocrinol. 2014. PMID: 24165019
The role of somatostatin analogs in Cushing's disease.
van der Hoek J, Lamberts SW, Hofland LJ. van der Hoek J, et al. Among authors: lamberts sw. Pituitary. 2004;7(4):257-64. doi: 10.1007/s11102-005-1404-x. Pituitary. 2004. PMID: 16132202 Review.
732 results